Email
Print
BCG Vaccine Market Overview
BCG Vaccine Market size in 2020 was estimated at $3.1 million, growing at a CAGR of 4.3% during the forecast period 2021-2026. BCG Vaccine is only vaccine that is majorly used for tuberculosis (TB). BCG vaccine help to prevent tuberculosis (TB) in adult and children that tested negative for tuberculosis (TB). Tuberculosis (TB) is infectious disease caused by Nontuberculous mycobacteria bacteria. Interferon-Gamma Release Assays (IGRAs) is blood test is performed to detect Mycobacterium tuberculosis (MTB) bacteria.
BCG vaccine is commonly used for treatment of early-stage bladder cancer. Increasing prevalence of tuberculosis (TB), and bladder cancer is major factor driving the growth of the market. Moreover, growing government focus on immunization programs further enhance the overall market demand for BCG Vaccine during the aforesaid period.
Report Coverage
The report: “BCG Vaccine Market – Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the BCG Vaccine Market:
By Type: Immune BCG, Therapy BCG
By Applications: Hospital, Clinics, others
By End-User: Pediatrics, Adults
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Others), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand and Others), South America(Brazil, Argentina and others), and Rest of the World (Middle East and Africa)
Key Takeaways
- In 2020, North America dominates the BCG Vaccine Market owing to rising incidence of bladder cancer.
- Increasing innovation and development in BCG Vaccine across the globe is driving the market growth of BCG Vaccine.
- Detailed analysis of the Strength, Weaknesses, and opportunities of the prominent players operating in the market will be provided in the BCG Vaccine Market report.
- Side effects of BCG vaccine includes fever, headache, and swollen gland and high cost of per dose of BCG vaccine are challenging the growth of the market.
For more details on this report - Request for Sample
BCG Vaccine Market Segment Analysis- By Type
Based on the type, BCG Vaccine Market is segmented into Immune BCG, Therapy BCG. The Immune BCG segment is estimated to dominate the market during the period 2021-2026. This is attributed to the vaccine which provides protection against infection with tuberculosis bacterium. Furthermore, it is more effective and safe as well as helps to build strong immunity system in the body. The Therapy BCG, segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 3.6% during the period 2021-2026. This is mainly owing to it plays important role in treatment of bladder cancer.
BCG Vaccine Market Segment Analysis- By Application
Based on the application, BCG Vaccine Market is segmented into Hospital, Clinics, others. In 2020, Hospital is estimated to hold major share in the market. This is mainly rising number of hospitals and the vaccine that is offered soon after birth. Moreover, increasing government initiatives to provide improved care top the patients in hospitals is also contributing to the dominance of this segment. Also, clinics is projected to grow with a CAGR of 3.0% over the period 2021-2026. This is owing to it is mostly preferred by patients owing to reduction in waiting time.
BCG Vaccine Market Segment Analysis- By Geography
North America dominated the BCG Vaccine market share accounting for 39% of the market in 2020. This is mainly owing to increasing prevalence of bladder cancer which leads to rise in demand for BCG Vaccine in the treatment of bladder cancer in this region. According to, Centres for Disease Control and Prevention (CDC), in the United States around 57,000 men and 18,000 women suffered from bladder cancer and out of them about 12,000 men and 5,000 women die owing to bladder cancer every year. However, the Asia-Pacific region is projected to be the fastest-growing over the period 2021-2026. This is owing to rising expenditure on healthcare coupled with rising advancement in vaccine market.
BCG Vaccine Market Drivers
Increasing Government Focus on Immunization Awareness.
Increasing government initiative and focus on immunization awareness through campaign across the globe is driving the growth of BCG Vaccine market. According to, World Health Organization (WHO), government initiative and immunization awareness prevent 3 million of deaths annually across the globe. Moreover, growing government support for development of BCG vaccine is also set to increase the market growth.
Rising Prevalence of Tuberculosis (TB)
Rising prevalence of tuberculosis (TB) which is caused by Nontuberculous mycobacteria and detect by Interferon-? release assays (IGRA) test is also driving the market. According to, World Health Organization (WHO), around 10 million people suffered from tuberculosis (TB) in 2019 across the world. Also, rising prevalence of bladder cancer in worldwide is also set to the growth of BCG Vaccine Market.
BCG Vaccine Market Challenges
Side effects of BCG vaccine includes fever, headache, and swollen gland is challenging the market. Along with this high cost of per dose of BCG vaccine are also further challenging the growth of the market.
Covid-19 Impact
Moreover, the outbreak of COVID-19 around the world has impacted all industries including healthcare industry. Covid- 19 affects the BCG Vaccine market including drastic reduction demand owing to lack of visits to healthcare facilities such as hospitals and clinics. Also owing to widespread of coronavirus it affects workforce and staffing issues, procedural prioritization. This affects BCG Vaccine market by cancellation of scheduled visit for primary care at hospitals and reflecting patients concern about infection.
BCG Vaccine Market Landscape
Product launches, Merger & Acquisitions, Joint Ventures and R&D activities are key strategies adopted by players in the BCG Vaccine Market. BCG Vaccine top 10 companies are Sanofi S.A., Merck Sharp & Dohme Corp., Serum Institute of India Ltd., GreenSignal Bio Pharma Limited (GSBPL), InterVax Ltd., Japan BCG Laboratory, Statens Serum Institute, Shanghai Institute of Biological Products, AJ Vaccine and China National Pharmaceutical Group Corporation
BCG Vaccine Market Development:
- In April 2020, Serum Institute of India launched human trails to test new BCG vaccine against corona virus and build immunity again COVID-19.
Relevant Reports:
Report Code: HCR 0397
Report Code: HCR 0226
For more Lifesciences and Healthcare Market reports, please click here
1. BCG Vaccine Market - Overview
1.1 Definitions and Scope
2. BCG Vaccine Market - Executive Summary
2.1 Market Revenue and Key Trends
2.2 Key trends by Type
2.3 Key trends by Application
2.4 Key trends by End User
2.5 Key trends by Geography
3. BCG Vaccine Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis –
3.5 Pricing Analysis
4. BCG Vaccine Market - Startup Companies Scenario Premium
4.1 Key Startup Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Venture Capital and Funding Scenario
5. BCG Vaccine Market – Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. BCG Vaccine Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. BCG Vaccine Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. BCG Vaccine Market – By Type(Market Size –$Million/$Billion)
8.1 Immune BCG
8.2 Therapy BCG
9. BCG Vaccine Market - By Application(Market Size –$Million/$Billion)
9.1 Hospital
9.2 Clinics
9.3 Others
10. BCG Vaccine Market - By End-User(Market Size –$Million/$Billion)
10.1 Pediatrics
10.2 Adults
11. BCG Vaccine Market - By Geography(Market Size –$Million/$Billion
11.1 North America
11.1.1 U.S.
11.1.2 Mexico
11.1.3 Canada
11.2 Europe
11.2.1 U.K.
11.2.2 France
11.2.3 Germany
11.2.4 Italy
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 India
11.3.3 Japan
11.3.4 South Korea
11.3.5 Australia & New Zealand
11.3.6 Rest of APAC
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Others
11.5 Rest of the World
11.5.1 Middle East
11.5.2 Africa
12. BCG Vaccine Market - Entropy
13. BCG Vaccine Market – Industry/Segment Competition Landscape Premium
13.1 Market Share Analysis
13.1.1 Global Market Share – Key Companies
13.1.2 Market Share by Region – Key companies
13.1.3 Market Share by Countries – Key Companies
13.1.4 Best Practices for Companies
14. BCG Vaccine Market – Key Company List by Country Premium Premium
15. BCG Vaccine Market Company Analysis
15.1 Company 1
15.2 Company 2
15.3 Company 3
15.4 Company 4
15.5 Company 5
15.6 Company 6
15.7 Company 7
15.8 Company 8
15.9 Company 9
15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
LIST OF TABLES
1.Global GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS Market 2023-2030 ($M)1.1 PEDIATRICS Market 2023-2030 ($M) - Global Industry Research
1.2 ADULTS Market 2023-2030 ($M) - Global Industry Research
2.Global GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS Market 2023-2030 (Volume/Units)
2.1 PEDIATRICS Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 ADULTS Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS Market 2023-2030 ($M)
3.1 PEDIATRICS Market 2023-2030 ($M) - Regional Industry Research
3.2 ADULTS Market 2023-2030 ($M) - Regional Industry Research
4.South America GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS Market 2023-2030 ($M)
4.1 PEDIATRICS Market 2023-2030 ($M) - Regional Industry Research
4.2 ADULTS Market 2023-2030 ($M) - Regional Industry Research
5.Europe GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS Market 2023-2030 ($M)
5.1 PEDIATRICS Market 2023-2030 ($M) - Regional Industry Research
5.2 ADULTS Market 2023-2030 ($M) - Regional Industry Research
6.APAC GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS Market 2023-2030 ($M)
6.1 PEDIATRICS Market 2023-2030 ($M) - Regional Industry Research
6.2 ADULTS Market 2023-2030 ($M) - Regional Industry Research
7.MENA GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS Market 2023-2030 ($M)
7.1 PEDIATRICS Market 2023-2030 ($M) - Regional Industry Research
7.2 ADULTS Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US BCG Vaccine Market Revenue, 2023-2030 ($M)2.Canada BCG Vaccine Market Revenue, 2023-2030 ($M)
3.Mexico BCG Vaccine Market Revenue, 2023-2030 ($M)
4.Brazil BCG Vaccine Market Revenue, 2023-2030 ($M)
5.Argentina BCG Vaccine Market Revenue, 2023-2030 ($M)
6.Peru BCG Vaccine Market Revenue, 2023-2030 ($M)
7.Colombia BCG Vaccine Market Revenue, 2023-2030 ($M)
8.Chile BCG Vaccine Market Revenue, 2023-2030 ($M)
9.Rest of South America BCG Vaccine Market Revenue, 2023-2030 ($M)
10.UK BCG Vaccine Market Revenue, 2023-2030 ($M)
11.Germany BCG Vaccine Market Revenue, 2023-2030 ($M)
12.France BCG Vaccine Market Revenue, 2023-2030 ($M)
13.Italy BCG Vaccine Market Revenue, 2023-2030 ($M)
14.Spain BCG Vaccine Market Revenue, 2023-2030 ($M)
15.Rest of Europe BCG Vaccine Market Revenue, 2023-2030 ($M)
16.China BCG Vaccine Market Revenue, 2023-2030 ($M)
17.India BCG Vaccine Market Revenue, 2023-2030 ($M)
18.Japan BCG Vaccine Market Revenue, 2023-2030 ($M)
19.South Korea BCG Vaccine Market Revenue, 2023-2030 ($M)
20.South Africa BCG Vaccine Market Revenue, 2023-2030 ($M)
21.North America BCG Vaccine By Application
22.South America BCG Vaccine By Application
23.Europe BCG Vaccine By Application
24.APAC BCG Vaccine By Application
25.MENA BCG Vaccine By Application
26.CHINA NATIONAL BIOTEC GROUP, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.GREENSIGNAL BIO PHARMA LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.INTERVAX LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.JAPAN BCG LABORATORY, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.MERCK CO., INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.SANOFI PASTEUR, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.SERUM INSTITUTE OF INDIA PVT. LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.STATENS SERUM INSTITUT, Sales /Revenue, 2015-2018 ($Mn/$Bn)